Indian site for Jubilant Generics lands Form 483 for QC issues
Generics giant Jubilant has one of its manufacturing sites under the FDA’s microscope.
A 14-page inspection report from late July and early August of this …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
